Amy Parker Fiebelkorn Selected Research

Amy Parker Fiebelkorn Research Topics

9	Mumps 10/2021 - 01/2013
8	Measles 06/2022 - 01/2013
7	Rubella (German Measles) 11/2018 - 01/2013
6	Human Influenza (Influenza) 10/2020 - 11/2016
3	Whooping Cough (Pertussis) 10/2020 - 01/2018
2	Tetanus 01/2018 - 01/2017
1	Chronic Disease (Chronic Diseases) 01/2024
1	COVID-19 07/2021
1	Diphtheria 01/2018
1	Hepatitis B 01/2017
1	Herpes Zoster 01/2017
1	Infections 01/2017
1	Pneumococcal Infections 01/2017
1	Vaccine-Preventable Diseases 01/2017
1	Congenital Rubella Syndrome (Syndrome, Congenital Rubella) 06/2013
1	HIV Infections (HIV Infection) 06/2013

8	Measles-Mumps-Rubella Vaccine (MMR Vaccine)IBA 10/2021 - 01/2013
7	VaccinesIBA 01/2020 - 01/2013
6	Influenza Vaccines (Influenza Vaccine)FDA Link 10/2020 - 11/2016
3	Neutralizing AntibodiesIBA 11/2018 - 12/2014
3	Hepatitis B Vaccines (Hepatitis B Vaccine)IBA 01/2018 - 01/2017
2	COVID-19 VaccinesIBA 01/2024 - 07/2021
2	Tetanus Toxoid (Vaccine, Tetanus)FDA Link 10/2020 - 09/2018
2	Diphtheria Toxoid (Vaccine, Diphtheria)FDA Link 10/2020 - 09/2018
2	Pneumococcal Vaccines (Pneumococcal Polysaccharide Vaccine)IBA 01/2017 - 01/2017
2	Rubella VaccineIBA 04/2016 - 06/2013
1	phenylalanylphenylalanineIBA 06/2022
1	Pertussis VaccineIBA 10/2020
1	AntibodiesIBA 01/2018
1	Herpes Zoster VaccineIBA 01/2017
1	Papillomavirus Vaccines (HPV Vaccines)IBA 01/2017
1	Immunoglobulin G (IgG)IBA 04/2016
1	Immunoglobulins (Immunoglobulin)IBA 06/2013

2	Long-Term Care 07/2021 - 09/2018
1	Art Therapy 06/2013